CNS Pharmaceuticals, Inc. (CNSP) Financials
CNSP Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| Dec. 31, 2025 | 8.6 million | 4.1 million |
| Sept. 30, 2025 | 11.9 million | 2.0 million |
| June 30, 2025 | 14.5 million | 1.4 million |
| March 31, 2025 | 13.7 million | 2.8 million |
CNSP Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| Dec. 31, 2025 | -3.1 million | 85068 |
| Sept. 30, 2025 | -2.2 million | 18452 |
| June 30, 2025 | -5.3 million | 21841 |
| March 31, 2025 | -3.2 million | 62367 |
CNSP Net Income
No data available :(
CNSP Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| Dec. 31, 2025 | 7.2 million | - | - |
| Sept. 30, 2025 | 9.9 million | - | - |
| June 30, 2025 | 12.1 million | - | - |
| March 31, 2025 | 13.0 million | - | - |
CNSP Shares Outstanding
CNSP Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| Dec. 31, 2025 | 18175 | 3.2 million | 2.8 million | - |
| Sept. 30, 2025 | - | 2.2 million | 1.1 million | - |
| June 30, 2025 | - | 1.2 million | 1.2 million | - |
| March 31, 2025 | - | 3.2 million | 1.1 million | - |
CNSP Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| Dec. 31, 2025 | - | -2898 |
| Sept. 30, 2025 | - | 697 |
| June 30, 2025 | - | 1101 |
| March 31, 2025 | - | 1100 |
CNSP
Price: $4.70
52 week price:
Earnings Per Share: 776.03 USD
P/E Ratio: 0.00
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 89600
Market Capitalization: 2.9 million